S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › 0HGM › Research report
← 0HGM page
XStocksXray
Market X-Ray report · 20 October 2026

Appian Corporation (0HGM)

London Exchange · UK · prices in USD · close of 20 Oct 2026

Key indicators

Last closeUSD 45.04
52-week range18.69 – 45.04
Return, 1 month / 3 months+18.0% / +99.3%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)67
Volatility (1 year)63.2%
Worst drawdown (1 year)-55.8%
Average daily value traded0.03M USD
Dividend yield–

Market X-Ray price-based

63/ 100 · Medium confidence · ahead of 71% of stocks on this exchange
Trend98
Momentum99
Stability (higher is calmer)16
Liquidity21
Income–

Five-year price chart navy: price · brown: 200-day average

17.4824.7632.0439.3246.602025-122026-022026-052026-082026-10

About the company

Appian Corporation provides a low-code software platform that organisations use to build applications and automate business processes. Its products combine process automation, data integration and artificial intelligence so that customers can design, deploy and manage their own applications. The company serves businesses and government agencies across industries such as financial services, healthcare, manufacturing and the public sector. Appian is based in McLean, Virginia, in the United States, and its software is used by organisations in many countries.

On this site Appian Corporation appears as a stock on the London Exchange (UK), code 0HGM, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Appian Corporation (0HGM) trades on the London Exchange in UK. It last closed at USD 45.04 on 20 October 2026.

Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,105 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Appian Corporation (0HGM)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend98 · StrongTrading above its long-term averages and near its highs.
Above 200-day average60.6%
From 52-week high0.0%
Momentum99 · StrongRising faster than most stocks on this exchange.
3-month return99.3%
6-month return111.0%
12-month return, skipping the last month–
Stability (higher is calmer)16 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)63.2%
Worst drawdown, 1 year (smaller is calmer)-55.8%
Liquidity21 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.03M USD
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+11.7%
1 month+18.0%
3 months+99.3%
6 months+111.0%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average37.96 / 28.04
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.31

Technical summary

DailyStrongly bullish11 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish6 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026